PC(22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

Metabolite details

Identifier

YDFZMLWRHJTSBW-LTFZHXBASA-N

InChI Key

YDFZMLWRHJTSBW-LTFZHXBASA-N

IUPAC name

[(2R)-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-[(7Z,10Z,13Z,16Z)-docosa-7,10,13,16-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

Preferred name

PC(22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

INN name

—

Synonym

—

ChEBI

CHEBI:178258

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• IDH1 Mutations Induce Organelle Defects Via Dysregulated Phospholipids (CSHpos)
• Lipidomic Changes in the Liver of Beagle Dogs Associated with Toxocara canis Infection
• Sexual dimorphism in the fetal cardiac response to maternal nutrient restriction.
• Absolute quantitative lipidomics reveals lipidome-wide alterations in aging brain (Mouse brain NEG UPLC-MS assay)
• LION-web validation lipidomics experiments (FA-incorporation, membrane fluidty)

Observed in differential profiles

• IDH1R132C_U251_ER_Untreated_vs_IDH1WT_U251_ER_Untreated
• Control_12h_vs_Toxocara canis_12h
• Control_Female_vs_Restricted_Female
• Control_Female_vs_Restricted_Female
• 4_weeks_vs_52_weeks
• BSA_Control_vs_AA